Etanercept Pen 50 mg/0.5 mL, 50 mg/1 mL Suppliers & Bulk Manufacturers

Available Forms: Pre-filled Syringe or Pen

Available Strengths: 50 mg/0.5 mL, 50 mg/1 mL

Reference Brands: Enbrel (US & EU)

Category: Arthritis

Etanercept is a recombinant fusion protein that binds to TNF-alpha, blocking its inflammatory effects. It reduces joint inflammation, pain, and tissue damage in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, disease progression slowing, and convenient subcutaneous administration, enhancing patient adherence and quality of life.

Product Description:

Etanercept pen is approved in the EU and US for the treatment of rheumatoid arthritis and other autoimmune diseases. In the EU, brands like Enbrel are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate efficient market access for etanercept pens, ensuring adherence to European and US standards for safe, effective biologic therapy and navigating complex regulatory frameworks seamlessly.